New front runners in Psychedelic Research emerge, as Texas put 50 million into Ibogaine R&D
On June 11th, 2025, Texas passed Senate Bill 2308, allocating $50 million in state funds towards the research and development of ibogaine for medical use. The bill had support from a large bipartisan majority and was signed by Gov. Greg Abbott, authorising universities, hospitals, and drug developers to work towards potential FDS-approved ibogaine treatments for veterans.